# Vascular Effects of Alirocumab in Acute MI-Patients

> **NCT03067844** · PHASE3 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 294 (actual)

## Conditions studied

- Coronary Vessel
- Coronary Circulation
- Atheroma; Myocardial

## Interventions

- **DRUG:** Alirocumab

## Key facts

- **NCT ID:** NCT03067844
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-25
- **Primary completion:** 2021-10-13
- **Final completion:** 2021-10-13
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2022-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03067844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03067844, "Vascular Effects of Alirocumab in Acute MI-Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03067844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*